Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | +1.50% | +15.34% | -86.21% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
Financials (USD)
Sales 2024 * | 102M | Sales 2025 * | 167K | Capitalization | 138M |
---|---|---|---|---|---|
Net income 2024 * | -105M | Net income 2025 * | -84M | EV / Sales 2024 * | 0.85 x |
Net cash position 2024 * | 51.6M | Net cash position 2025 * | 168M | EV / Sales 2025 * | -182 x |
P/E ratio 2024 * |
-1.32
x | P/E ratio 2025 * |
-1.71
x | Employees | 384 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.13% |
Latest transcript on Amylyx Pharmaceuticals, Inc.
1 day | +1.50% | ||
1 week | +15.34% | ||
Current month | +12.15% | ||
1 month | -22.22% | ||
3 months | -87.14% | ||
6 months | -88.99% | ||
Current year | -86.21% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 12-12-31 |
Josh Cohen
FOU | Founder | 33 | 12-12-31 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 14-12-31 |
Kari Firestone
BRD | Director/Board Member | - | 23-03-15 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 21-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.09% | 237 M€ | +1.82% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +6.90% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 2.03 | +1.50% | 1,478,023 |
24-05-02 | 2 | +3.63% | 1,911,403 |
24-05-01 | 1.93 | +6.63% | 1,803,267 |
24-04-30 | 1.81 | -4.74% | 1,882,747 |
24-04-29 | 1.9 | +7.95% | 2,101,194 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.21% | 138M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- AMLX Stock